Genentech and Pieris Collaborate on Respiratory and Ophthalmology Therapies
By Michelle Liu
Pharma Deals Review: Vol 2021 Issue 6 (Table of Contents)
Published: 17 Jun-2021
DOI: 10.3833/pdr.v2021.i6.2614 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Genentech has partnered with Pieris Pharmaceuticals to discover, develop and commercialise locally-delivered respiratory and ophthalmology therapies based on Pieris' Anticalin® technology...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS